Khiron Life Sciences Announces Launch of Khiron Clinics

Published: October 24, 2018

Khiron Life Sciences Announces Launch of Khiron Clinics

Khiron Life Sciences Corp., an integrated medical cannabis company with its core operations in Colombia, has signed the definitive agreement for the acquisition of the Latin American Institute of Neurology and the Nervous System (“ILANS”) previously announced on August 7, 2018. ILANS is one of the most respected, fastest growing, and largest neurological clinics in Colombia, and becomes a cornerstone of the Khiron Clinics business unit in Latin America.

The ILANS network represents 100,000 patients in Colombia and will position Khiron with approximately C$10.5 Millionin gross revenue and C$1.8 Million of EBITDA (2017 Audited Financial Statements). The ILANS acquisition provides a secure revenue stream.

Alvaro Torres, Khiron Co-founder and Chief Executive Officer stated, “After the closing of the ILANS agreement, we generate immediate revenue and greatly reduce patient acquisition costs. With Dr. Jairo Espinoza, ILANS´ founder and one of Colombia´s most respected specialists joining our senior executive management team, we are positioned to leverage the existing ILANS patient base to grow the Khiron Clinics business unit throughout Colombia and across Latin America, in keeping with our clinic expansion strategy.”

Material terms set forth in the definitive agreement include:

  • Issuance of 1,400,000 common shares, at C$1.50 per share, upon closing of the transaction
  • Cash payment of C$4,730,000 over a period of two years. The future cash payments will be secured by a promissory note
  • Cash payment of C$5.0 million for the attainment of milestones pertaining to patient acquisition up to a period of two years after closing of the transaction

The closing of this acquisition is subject to approval from the TSX Venture Exchange.

Recent News

View All News Items

Latest Article

How Database Integrations Can Improve Every Step in Your Cannabis Supply Chain Labeling

How Database Integrations Can Improve Every Step in Your Cannabis Supply Chain Labeling

At any step in the cannabis supply chain, your labeling system should allow for full control and traceability, from seed to sale. Implementing lean principles and labeling best practices across the cannabis supply chain can help you streamline your seed-to-sale labeling process and help you gain control.

Click below to read the full blog and learn how to reduce waste, cut costs, and gain efficiency with cannabis labeling:

Read Article